Securing supply for this medication and abaloparatide can be challenging, as they are restricted medications primarily prescribed for osteoporosis care in people at significant risk for fractures. Generally, these therapies are unavailable over-the-top and necessitate a medical authorization. A physician is the initial point of contact for evaluati